Delivery Order SPE2DE21D7001-SPE2D623F3DE3
- Not listed
- This federal contract award is for the delivery of BIOLOGICS - SYNTHETICS-MASTERGRAFT STRIP medical devices, valued at $6,720.30, by Medtronic Inc. through its Medtronic USA, Inc. division. The contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense, and does not have a set-aside designation. Medtronic is a global leader in medical technology, specializing in innovative medical devices and therapies. The company has a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Health Agency (DHA), a component of the Department of Defense (DoD), to Medtronic Inc. through its Medtronic USA, Inc. division. The $8,181.40 fixed-price delivery order contract is for the supply of BIOLOGICS - SYNTHETICS-MASTERGRAFT STRIP medical products. Medtronic is a global leader in medical technology and has been awarded numerous federal contracts and grants to provide a wide range of innovative medical devices and therapies to the...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order valued at $10,074.75 by the Defense Department's Medical Supply Chain for biologics and synthetics, specifically MasterGraft Strip products. The contract, awarded on May 20, 2025, utilizes fixed-price pricing with economic price adjustment provisions and carries an ultimate completion date of May 23, 2025. The award was made without a set-aside designation, reflecting full and open competition. Performance...
- This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Medtronic Inc., a global medical technology and services company. The $8,378.05 fixed-price with economic price adjustment contract is for the delivery of Biologics - Synthetics-Mastergraft Strip medical products, with a completion date of February 7, 2024. Medtronic Inc. is the prime contractor and there is no set-aside designation for this award. Medtronic Inc. has a strong track record of supplying...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order valued at $3,507.40 by the Defense Health Agency's Medical Supply Chain division for Biologics - Synthetics MasterGraft Strip on July 18, 2025. The contract employs a fixed-price with economic price adjustment pricing model and carries no set-aside designation, reflecting the vendor's competitive capabilities in federal procurement. Performance will be executed in Fridley, Minnesota, with an ultimate...
- The U.S. government has awarded a $5,702.85 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of Biologics - DBM-TS-OTI Grafton DBM Matrix medical products. This contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD) that oversees the Military Health System. The contract has an ultimate completion date of December 9, 2024 and does not have a set-aside designation. Medtronic is a...
- This federal contract award was issued by the Defense Health Agency (DHA), an agency within the Department of Defense (DoD), to Medtronic Inc. through its Medtronic USA, Inc. division. The $2,274.30 fixed-price contract with economic price adjustment is for the delivery of BIOLOGICS - DBM-TS-GRAFTON DBF medical products, which are likely specialized surgical implants or biologics used in the treatment of military personnel and veterans. The contract does not have a set-aside designation and is...
- Medtronic Inc., through its Medtronic USA division, was awarded a delivery order valued at $9,753.65 on July 31, 2025, for the supply of Biologics—Synthetics MasterGraft Strip, a specialized medical product. The contract is a fixed-price agreement with economic price adjustment provisions and will be performed in Fridley, Minnesota, with an ultimate completion date of August 7, 2025. This delivery order was awarded without set-aside designation through the Defense Health Agency's Medical...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Medtronic Inc., a global medical technology company, for the procurement of "BIOLOGICS - SYNTHETICS-MASTERGRAFT STRIP" medical supplies. The contract has an ultimate completion date of October 29, 2024 and a ceiling value of $5,629.70. The contract is not set-aside and is a Fixed Price with Economic Price Adjustment type. Medtronic's Medtronic USA, Inc. division is the prime contractor on this...
- Medtronic Inc.'s Medtronic USA division was awarded a delivery order on August 20, 2025, for biologics and synthetic products, specifically Mastergraft Strip, with a ceiling value of $5,367.50. This fixed-price contract with economic price adjustment has a completion date of September 5, 2025, and will be performed in Fridley, Minnesota. The contract was awarded without a set-aside designation through the Defense Health Agency's Medical Supply Chain, reflecting the agency's need for...
- SPE2DE21D7001Indefinite Delivery Contract
- SPE2DE21D7001-SPE2D623F3DE3Delivery Order
This federal contract award is for the delivery of Mastergraft Strip biological products to the Defense Health Agency (DHA), a component of the Department of Defense that manages the Military Health System. The $14,952.05 fixed-price contract with economic price adjustment was awarded to Medtronic Inc. through its Medtronic USA, Inc. division. The award has an ultimate completion date of July 24, 2023. Medtronic is a global medical technology company that provides a wide range of innovative devices and therapies to federal agencies. This contract is part of Medtronic's significant Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs, valued at up to $600 million, for providing surgical implants and related products and services through December 2028. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 5/9/23 |